Trans Genic Inc.(JP:2342)
Â¥165.00-14.00 (-7.82%)
JP:2342
Trans Genic Inc. financials statements
Â¥165.00
At close:-14.00 (-7.82%)
Want to see JP:2342 full AI Analyst Report?
Trans Genic Inc. (2342) Ratios
0 Followers
Trans Genic Inc. Ratios
JP:2342's free cash flow for Q4 2025 was ¥0.00. For the 2025 fiscal year, JP:2342's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.74 | 2.05 | 2.69 | 2.76 | 2.90 |
| Quick Ratio | 1.10 | 1.37 | 1.78 | 1.94 | 2.25 |
| Cash Ratio | 0.55 | 0.78 | 1.02 | 1.26 | 1.74 |
| Solvency Ratio | 0.02 | -0.19 | 0.04 | -0.05 | 0.55 |
| Operating Cash Flow Ratio | 0.01 | 0.03 | -0.16 | -0.52 | 0.67 |
| Short-Term Operating Cash Flow Coverage | 0.02 | 0.08 | -0.43 | -2.16 | 2.46 |
| Net Current Asset Value | ¥ 1.81B | ¥ 1.97B | ¥ 2.74B | ¥ 3.01B | ¥ 3.91B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.27 | 0.23 | 0.23 | 0.17 |
| Debt-to-Equity Ratio | 0.44 | 0.54 | 0.38 | 0.40 | 0.28 |
| Debt-to-Capital Ratio | 0.30 | 0.35 | 0.28 | 0.29 | 0.22 |
| Long-Term Debt-to-Capital Ratio | 0.17 | 0.22 | 0.18 | 0.22 | 0.14 |
| Financial Leverage Ratio | 2.04 | 2.01 | 1.66 | 1.77 | 1.60 |
| Debt Service Coverage Ratio | 0.34 | -0.38 | 0.21 | -0.33 | 2.81 |
| Interest Coverage Ratio | 3.01 | -6.96 | 1.88 | -0.88 | 81.17 |
| Debt to Market Cap | 0.49 | 0.85 | 0.56 | 0.42 | 0.24 |
| Interest Debt Per Share | 128.18 | 157.02 | 137.16 | 145.21 | 107.58 |
| Net Debt to EBITDA | -0.16 | -0.31 | -0.92 | 8.70 | -0.93 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.47% | 16.66% | 17.19% | 17.45% | 30.50% |
| EBIT Margin | 1.05% | -1.96% | 0.69% | -2.65% | 22.19% |
| EBITDA Margin | 2.23% | -0.49% | 1.84% | -1.05% | 24.00% |
| Operating Profit Margin | 1.05% | -1.96% | 0.68% | -0.22% | 14.61% |
| Pretax Profit Margin | -1.57% | -5.20% | 0.33% | -2.90% | 22.01% |
| Net Profit Margin | -0.59% | -8.38% | 0.03% | -3.58% | 14.92% |
| Continuous Operations Profit Margin | -0.74% | -8.39% | 0.03% | -3.85% | 14.79% |
| Net Income Per EBT | 37.25% | 161.20% | 9.48% | 123.47% | 67.80% |
| EBT Per EBIT | -150.36% | 265.25% | 48.17% | 1319.32% | 150.63% |
| Return on Assets (ROA) | -0.79% | -11.37% | 0.04% | -3.84% | 17.97% |
| Return on Equity (ROE) | -1.62% | -22.88% | 0.07% | -6.81% | 28.72% |
| Return on Capital Employed (ROCE) | 2.34% | -4.04% | 1.21% | -0.32% | 23.61% |
| Return on Invested Capital (ROIC) | 0.92% | -3.38% | 0.10% | -0.29% | 14.48% |
| Return on Tangible Assets | -0.84% | -12.06% | 0.04% | -4.05% | 18.65% |
| Earnings Yield | -1.81% | -35.80% | 0.10% | -7.33% | 25.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.30 | 10.88 | 9.79 | 10.62 | 14.09 |
| Payables Turnover | 25.84 | 26.21 | 39.23 | 23.08 | 34.14 |
| Inventory Turnover | 4.34 | 4.88 | 4.86 | 4.22 | 5.10 |
| Fixed Asset Turnover | 6.61 | 6.33 | 6.11 | 5.74 | 6.31 |
| Asset Turnover | 1.35 | 1.36 | 1.33 | 1.07 | 1.20 |
| Working Capital Turnover Ratio | 4.19 | 3.45 | 2.93 | 2.32 | 2.89 |
| Cash Conversion Cycle | 102.19 | 94.44 | 103.02 | 105.14 | 86.83 |
| Days of Sales Outstanding | 32.29 | 33.54 | 37.27 | 34.36 | 25.91 |
| Days of Inventory Outstanding | 84.03 | 74.83 | 75.05 | 86.59 | 71.61 |
| Days of Payables Outstanding | 14.12 | 13.92 | 9.30 | 15.81 | 10.69 |
| Operating Cycle | 116.31 | 108.37 | 112.32 | 120.95 | 97.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.56 | 5.66 | -23.36 | -84.90 | 104.43 |
| Free Cash Flow Per Share | -2.56 | -4.89 | -39.17 | -103.08 | 73.38 |
| Dividend Paid and CapEx Coverage Ratio | 0.38 | 0.42 | -1.12 | -3.51 | 3.06 |
| Capital Expenditure Coverage Ratio | 0.38 | 0.54 | -1.48 | -4.67 | 3.36 |
| Operating Cash Flow Coverage Ratio | 0.01 | 0.04 | -0.17 | -0.59 | 0.98 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.01 | -0.03 | -0.13 | 0.14 |
| Free Cash Flow Yield | -1.00% | -2.67% | -16.53% | -31.05% | 17.27% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -55.17 | -2.79 | 974.79 | -13.65 | 3.88 |
| Price-to-Sales (P/S) Ratio | 0.32 | 0.23 | 0.30 | 0.49 | 0.58 |
| Price-to-Book (P/B) Ratio | 0.89 | 0.64 | 0.68 | 0.93 | 1.11 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -100.19 | -37.42 | -6.05 | -3.22 | 5.79 |
| Price-to-Operating Cash Flow Ratio | 164.54 | 32.35 | -10.15 | -3.91 | 4.07 |
| Price-to-Earnings Growth (PEG) Ratio | 0.59 | 0.00 | -9.65 | 0.11 | 0.02 |
| Enterprise Value Multiple | 14.37 | -47.59 | 15.61 | -37.97 | 1.49 |
| Enterprise Value | 4.22B | 3.06B | 3.76B | 4.55B | 4.48B |
| EV to EBITDA | 14.37 | -47.59 | 15.61 | -37.97 | 1.49 |
| EV to Sales | 0.32 | 0.24 | 0.29 | 0.40 | 0.36 |
| EV to Free Cash Flow | -99.11 | -37.66 | -5.71 | -2.62 | 3.57 |
| EV to Operating Cash Flow | 162.76 | 32.56 | -9.58 | -3.18 | 2.51 |
| Tangible Book Value Per Share | 260.24 | 258.66 | 325.29 | 329.79 | 365.33 |
| Shareholders’ Equity Per Share | 287.04 | 286.34 | 350.80 | 357.29 | 381.31 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.53 | -0.61 | 0.91 | -0.33 | 0.33 |
| Revenue Per Share | 791.10 | 781.88 | 778.70 | 678.57 | 734.08 |
| Net Income Per Share | -4.64 | -65.51 | 0.24 | -24.32 | 109.52 |
| Tax Burden | 0.37 | 1.61 | 0.09 | 1.23 | 0.68 |
| Interest Burden | -1.50 | 2.65 | 0.48 | 1.09 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.17 | 0.18 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.34 | -0.09 | -96.07 | 2.42 | 0.95 |
Currency in JPY

